Our mission is to raise money so that the Human Genetics Program can continue to aggressively pursue genetic research in hereditary colon cancer and design intervention.
The Human Cancer Genetics Programs fund work led by researchers at Ohio State University’s Comprehensive Cancer Center. Currently this research is embarking upon a link to a specific gene conclusively as a cause of colon cancer. It will eventually provide clinicians with a new way to identify people who are at high risk for colon cancer.
1. The genetic research provides clinicians with a new way to identify people who are at high risk for colon cancer.
2. An estimated 1 million cases of colon cancer arise each year worldwide, making it the second- to fourth-most-common cancer in industrialized nations.
3. It is the third-most-common cancer and cancer killer in the United States, with 149,000 new cases and 50K deaths from the disease expected this year.